The beta-agonist controversy. Impact in COPD.
Ziment
I
I
Olive View UCLA Medical Center, Sylmar, USA.
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents